Fundraising Fox

Glaukos

NYSE: GKOS

1 known investors

glaukos.com β†—

Glaukos develops ophthalmic therapies for chronic eye diseases, including corneal cross-linking for keratoconus, glaucoma treatments, and sustained-release drug delivery platforms for retinal diseases. It serves ophthalmic surgeons and patients worldwide with its portfolio of medical treatments and devices.

BiotechHealthtechMedical Devices

Investors Β· 1

Competitors Β· 4

by search overlap

Companies competing with Glaukos for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Glaukos do?
Glaukos develops ophthalmic therapies for chronic eye diseases, including corneal cross-linking for keratoconus, glaucoma treatments, and sustained-release drug delivery platforms for retinal diseases. It serves ophthalmic surgeons and patients worldwide with its portfolio of medical treatments and devices.
Who are Glaukos's investors?
Glaukos's investors include Avedro, Inc..